Predictive implications of stress testing. Follow-up
of 2700 subjects after maximum treadmill stress testing
M. H. Ellestad, M. K. Wan
Prior to the publication of this paper, controversy
had surrounded the usefulness of exercise testing
in reliably diagnosing coronary artery disease...
Value of the history and physical in identifying patients at
increased risk for coronary events
D. B. Pryor, L. Shaw, C.B. McCants, K. L. Lee, D. B. Mark, F. E. Harrell Jr, L. H. Muhlbaier, R. M. Califf
Much has been written about the predictive
value of noninvasive testing in evaluating
patients with cardiac symptoms for the
likelihood of coronary artery disease
(CAD), assessing prognosis, and guiding
the need for further investigation...
Survival of medically treated patients in the coronary
artery surgery study (CASS) registry
M. B. Mock, I. Ringqvist, L. D. Fisher, K. B. Davis, B. R. Chaitman, N.T. Kouchoukos, G. C. Kaiser,
E. Alderman, T. J. Ryan, R. O. Russel Jr, S. Mullin, D. Fray, T. Killip 3rd
Prior to the widespread use of coronary angiography
to quantify atherosclerotic burden, studies
had reported varying survival rates for patients
with coronary artery disease (CAD), ranging from
15% to 75% at 5 years...
Collaborative overview of randomised trials of antiplatelet
therapy—I: Prevention of death, myocardial infarction, and stroke
by prolonged antiplatelet therapy in various categories of patients
Antiplatelet Trialists’ Collaboration
As far back as the fifth century BC, Hippocrates
made therapeutic use of willow bark to ease
aches and reduce fever...
Randomised trial of cholesterol lowering in 4444 patients with
coronary heart disease: the Scandinavian Simvastatin Survival
Study (4S)
For the best part of the last century, the observation
that atherosclerotic plaque contains a lipidrich
core has fuelled the belief that the buildup of
coronary atherosclerosis is a direct result of high
serum cholesterol...
Circadian variation of total ischaemic burden and its alteration
with anti-anginal agents
D. Mulcahy, J. Keegan, D. Cunningham, A. Quyyumi, P. Crean, A. Park, C. Wright, K. Fox
How antianginal therapy impacts upon the
circadian variation of ischemic episodes in
patients with coronary artery disease is
illustrated in this important paper...
The pathogenesis of atherosclerosis: a perspective for the 1990s
R. Ross
In this landmark review, the late Russell Ross has
not only provided a perspective for the 1990s, but
also insight into fundamental shifts in therapeutics
extending into the first decade of the millennium...
Analysis of probability as an aid in the clinical diagnosis of
coronary-artery disease
G. A. Diamond, J. S. Forrester
Diamond and Forrester provide an interesting
insight into the planning of noninvasive tests
to diagnose coronary artery disease (CAD)...
Effect of coronary artery bypass graft surgery on survival:
overview of 10-year results from randomised trials by the
Coronary Artery Bypass Graft Surgery Trialists Collaboration
S. Yusuf, D. Zucker, P. Peduzzi, L. Fisher, T. Takaro, J. W. Kennedy, K. Davis, T. Killip,
E. Passamani, R. Norris, et al
This paper complements Bucher’s meta-analysis
of percutaneous transluminal coronary angioplasty
(PTCA) versus medical therapy...
Percutaneous transluminal coronary angioplasty versus medical
treatment for non-acute coronary heart disease: meta-analysis of
randomised controlled trials
H. C. Bucher, P. Hengstler, C. Schindler, G. H. Guyatt
The efficacy of percutaneous transluminal coronary
angioplasty (PTCA) versus medical therapy
in the treatment of stable coronary disease
has not been addressed with the same level of
interest as the comparison of PTCA with coronary
artery bypass surgery (CABG)...
|
